YB Peptide Retatrutide
As of 9 Aug 2026, Finnrick has published 8 independent lab tests of Retatrutide from YB Peptide: 8 passed and 0 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 28 Apr 2026. The current Finnrick rating for YB Peptide Retatrutide is 86%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 28 Apr 2026 | Pass | Certificate 9ubuu2s |
| 12 Mar 2026 | Pass | Certificate f2ztpet |
| 10 Feb 2026 | Pass | Certificate 94x5gah |
| 29 Dec 2025 | Pass | Certificate zvmup7x |
| 25 Nov 2025 | Pass | Certificate atv58rh |
| 18 Sep 2025 | Pass | Certificate 2speakv |
| 15 Sep 2025 | Pass | Certificate eh2fbp3 |
| 21 Aug 2025 | Pass | Certificate mbnbn4a |